CatalystPit

CRBUCaribou Biosciences, Inc.

NASDAQ · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Last close $1.27 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Market cap$136.15M
CountryUSA
RECENT INSIDER TRADES
  • 2026-02-27 · Kelly Timothy P (Chief Technology Officer) · SELL
  • 2026-02-24 · Albertson Tina M. (Chief Medical Officer) · SELL
  • 2026-02-24 · MCCLUNG BARBARA G (Chief Legal Officer) · SELL
  • 2026-02-24 · Kelly Timothy P (Chief Technology Officer) · SELL
  • 2026-02-24 · Khan Ruhi Ahmad (Chief Business Officer) · SELL
INSTITUTIONAL OWNERSHIP
Institutional holders147
Shares held61,211,870
Value$100.95M
Percent of shares outstanding57.10%
As of quarter end2026-06-30
RECENT NEWS
  • Caribou Biosciences halts CAR-T programs, explores strategic alternatives
  • Caribou Biosciences to Evaluate Strategic Alternatives
  • CRBU halted · News pending
  • CRBU halted · News released
  • CRBU halted · News & resumption times
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
Caribou Biosciences, Inc. (CRBU) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit